Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
CEO of Israeli drug maker Teva Pharmaceutical Industries Ltd.'s... News Photo - Getty Images
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva sees higher margins, lower debt from restructuring | Financial Times
Teva CEO tells PM no bending on mass redundancy plan
Teva neck-deep in legal trouble with no end in sight | Ctech
Teva Pharmaceutical Industries names a new CEO
U.S. accuses Israel's Teva of fixing drug prices
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva made smart decision to move to us: Allergan CEO
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Shlomo Yanai, incoming president and CEO of Teva Pharmaceutical Industries, Ltd., takes part in the opening bell ceremonies at the NASDAQ in New York on February 21, 2007. (UPI Photo/Laura Cavanaugh Stock
Teva CEO stands down during troubled times - MedCity News
Mexico's social security agency sues Israel's Teva for allegedly bribing doctors - Business - Haaretz.com
Teva Pharma CEO: We see a stable U.S. market place for our generics - The Global Herald
US Congress grills Teva CEO on Copaxone price hikes - Globes
Where is Kåre Schultz? | Ctech
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel - YouTube
Who's Kare Schultz, (NYSE:TEVA) New CEO In Charge Of Teva? | Benzinga
Teva Announces Changes to Executive Management Team | Business Wire
Teva CEO to Step Down, Be Replaced by Chairman | Fortune
Teva finally announces successful CEO appointment | Pharmafile
Teva CEO reportedly wanted to stay in his job | The Times of Israel
After turbulent years, Teva CEO Schultz forecasts stability - The Jerusalem Post
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma
